HC Wainwright Reiterates Buy Rating for Sana Biotechnology (NASDAQ:SANA)
Sana Biotechnology (NASDAQ:SANA – Get Free Report)‘s stock had its “buy” rating restated by investment analysts at HC Wainwright in a report released on Tuesday,Benzinga reports. They presently have a $11.00 price target on the stock. HC Wainwright’s target price indicates a potential upside of 370.09% from the company’s previous close. Several other brokerages also […]
